We are especially committed to covering discussions about value, since The American Journal of Managed Care has been a leader in encouraging stakeholders to discuss the challenge of paying for innovations in cancer care.
PLAINSBORO, N.J. (PRWEB) July 21, 2015
The promise of precision medicine is becoming a reality, and nowhere was that more apparent than at the 2015 meeting of the American Society of Clinical Oncology (ASCO) in Chicago’s McCormick Center. Now, a recap of the meeting is available in Evidence-Based Oncology, a publication of The American Journal of Managed Care; the issue can be found online.
Clinical sessions highlighted in the special issue include those on predictive biomarkers immuno-oncology, selection of lymphoma regimens, and new options in treating melanoma and multiple myeloma. The issue also covers the nation’s largest precision medicine trial in oncology, sponsored by the National Cancer Institute and outlined at ASCO.
This edition of EBO also includes sessions on ASCO’s yearlong discussion of what constitutes value in cancer care, as well as the growing administrative burdens on oncologists as they keep track of new measurements that track quality. Related coverage of these issues, which were addressed at the Stakeholders’ Summit convened by The American Journal of Managed Care, is also featured in the issue.
“We are especially committed to covering discussions about value, since The American Journal of Managed Care has been a leader in encouraging stakeholders to discuss the challenge of paying for innovations in cancer care,” said Brian Haug, president of AJMC. “We encourage everyone involved in oncology to read this issue and follow http://www.ajmc.com for our coverage of these topics.”
About the Journals
The American Journal of Managed Care celebrates its 20th year in 2015 as the leading peer-reviewed journal dedicated to issues in managed care. Other titles in the franchise include The American Journal of Pharmacy Benefits, which provides pharmacy and formulary decision-makers with information to improve the efficiency and health outcomes in managing pharmaceutical care, and The American Journal of Accountable Care, which publishes research and commentary on new healthcare delivery models facilitated by the 2010 Affordable Care Act. AJMC’s news publications, the Evidence-Based series, bring together stakeholder views from payers, providers, policymakers and pharmaceutical leaders in oncology and diabetes management. To order reprints of articles appearing in AJMC publications, please call (609) 716-7777, x 131.
Nicole Beagin (609) 716-7777 x 131